Established players in Japan's immunology market dominate branded digital marketing space, finds GlobalData

GlobalData reveals role of Japan’s immunology market in branded digital marketing space
GlobalData reveals role of Japan’s immunology market in branded digital marketing space
15 December 2020 | Analysis
Photo Credit: GlobalData
The Japanese immunology market is highly competitive with many innovator products available for rheumatoid arthritis (RA), psoriasis (PsO), psoriatic arthritis (PsA), inflammatory bowel disease (IBD) comprising ulcerative colitis (UC) and Crohn’s disease (CD), and ankylosing spondylitis (AS) indications. Across these indications, the branded support available for initially approved therapies dominate the digital marketing space compared to the support available for newly approved products, finds GlobalData, a leading data and analytics company.

Related Keywords

Japan ,Japanese ,Abbvie Rinvoq Jan ,Astella Smyraf Mar ,Janssen Tremfya Mar ,Sanofi Kevzara Sep ,Janssen Remicare ,Venkat Kartheek Vale ,Abbvie Skyrizi Mar ,Ilumya Jun ,Globaldata Pharmaceutical Intelligence Center ,Pharmaceutical Intelligence Center ,Kartheek Vale ,Pharma Analyst ,Kyowa Kirin ,Astella Smyraf ,ஜப்பான் ,ஜப்பானிய ,மருந்து உளவுத்துறை மையம் ,பார்மா ஆய்வாளர் ,கியோவா கிரீன் ,